<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">This protocol is described using the 2013 SPIRIT guidelines on standard protocol items for clinical trials [
 <xref ref-type="bibr" rid="CR20">20</xref>]. The trial is designed as a two-group, superiority, randomised, participant-, interventionist- and assessor-blinded placebo-controlled trial, to be conducted in Melbourne and Sydney over 4 years. The primary end-point for analysis of outcomes is 12 months after baseline assessment.
</p>
